Inverse correlation between trabecular bone volume and bone marrow adipose tissue in rats treated with osteoanabolic

Samantha Costa1, Heather Fairfield1, Michaela R Reagan1

  • 1Maine Medical Center Research Institute, Scarborough, ME, USA; University of Maine Graduate School of Biomedical Science and Engineering, Orono, ME, USA; Tufts University School of Medicine, Boston, MA, USA.

Bone
|April 8, 2019
PubMed

Insights

Sclerostin-neutralizing antibodies (Scl-Ab) and human parathyroid hormone (hPTH) treatments impact bone marrow adiposity differently. Long-term Scl-Ab reduces adiposity by increasing bone, while hPTH directly decreases adipocytes in males.

Area of Science:

  • Bone Biology and Disease
  • Endocrinology
  • Skeletal Therapeutics

Background:

  • Unmet clinical need exists for improved treatments for skeletal diseases like osteoporosis and cancer-induced bone disease.
  • Novel therapeutic targets and mechanisms of action for established therapies are incompletely understood.
  • Anabolic treatments, including sclerostin-neutralizing antibodies (Scl-Ab) and human parathyroid hormone (hPTH), show promise for stimulating bone formation.

Purpose of the Study:

  • To define the effects of anabolic treatments (Scl-Ab and hPTH) on bone and bone marrow adipocytes (BMA).
  • To compare two methods for assessing marrow adiposity: within total tissue area (T.Ar) and within marrow area (Ma.Ar).

Main Methods:

  • Male and female rats received vehicle, Scl-Ab (3 or 50 mg/kg weekly), or hPTH (75 μg/kg daily) for 4 or 26 weeks.
  • Histological analyses of distal femurs were performed using a novel ImageJ method.
  • Adipocyte number, circumference, and total adipose area were quantified within T.Ar and Ma.Ar.

Main Results:

  • After 26 weeks, a significant inverse correlation between bone and total tissue adiposity (in T.Ar) was observed in both sexes (p < 0.0001).
  • Scl-Ab treatments showed no significant effect on adipocytes based on marrow adiposity (in Ma.Ar) after 26 weeks.
  • Chronic hPTH treatment significantly reduced adipocyte number and adiposity within both T.Ar and Ma.Ar in males.

Conclusions:

  • Long-term Scl-Ab treatment decreases total tissue adiposity primarily by increasing trabecular bone, reducing available space for adipocytes.
  • hPTH treatment directly reduces adipocyte number and adiposity, particularly in males.
  • The choice of adiposity measurement (T.Ar vs. Ma.Ar) is critical and should be considered based on study relevance.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
989
Bone Cells and Tissue01:30

Bone Cells and Tissue

Bones contain a relatively small number of cells entrenched in a matrix of organic and inorganic components. Although bone cells compose only a small amount of the bone volume, they are crucial to its function. Four types of cells are found within the bone tissue— osteoblasts, osteocytes, osteogenic cells, and osteoclasts.
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
8.2K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
4.1K
Bone as Supporting Connective Tissue01:23

Bone as Supporting Connective Tissue

Bone tissue forms the internal skeleton of vertebrate animals, providing structure to the body.
Bone Matrix
Bone, or osseous tissue, is a connective tissue that has a large amount of two different types of matrix material. The organic matrix is similar to the matrix material found in other connective tissues, including some amount of collagen and elastic fibers. This gives strength and flexibility to the tissue. The inorganic matrix consists of mineral salts— mostly calcium salts—...
6.6K
Spongy Bone01:09

Spongy Bone

All bones comprise an outer layer of compact bone, and an interior made up of spongy bone tissue, also called cancellous or trabecular bone. In long bones, spongy bone tissue is mainly found in the interior of the epiphyses (broad ends of the bone).
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
7.7K